Page 12 - Numeric Rating Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Common Outcome Measures for AD Lack Adequate Reporting of Race
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
An Effective Alternative to Opioids for Acute Pain?
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Postsurgical Percutaneous Nerve Stimulation Cuts Pain, Opioid Use
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Feb 5, 2021
THURSDAY, Feb. 4, 2021 (HealthDay News) Listening to recorded music is associated with a significant reduction in anxiety and pain following cardiac surgery, according to a review published online Jan. 25 in
Open Heart.
Ellaha Kakar, from Erasmus Medical Center in Rotterdam, Netherlands, and colleagues conducted a systematic literature search and meta-analysis of randomized controlled trials evaluating music interventions in cardiac surgery.
Based on 20 eligible studies for qualitative analysis (1,169 patients) and 16 studies for meta-analysis (987 patients), the researchers found that the first postoperative music session was associated with significantly reduced postoperative anxiety and pain. There were reductions of 4.00 points on the State-Trait Anxiety Inventory and 1.05 points on the Visual Analogue Scale/Numeric Rating Scale for anxiety and a reduction of 1.26 points on the Visual Analogue Scale/Numeric Rating Scale for pain. Multiple days of music interven
Press release content from Business Wire. The AP news staff was not involved in its creation.
Novaremed Secures US $50 Million Capital Commitment from Global Emerging Markets
January 28, 2021 GMT
BASEL, Switzerland (BUSINESS WIRE) Jan 28, 2021
Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced today that it has signed an agreement with GEM Global Yield LLC SCS (GEM), a Luxembourg-based private, alternative investment group for a US $50 million capital commitment.
Under the agreement, GEM commits to provide Novaremed with a share subscription facility of up to US $50 million for a 36-month term following the public listing of the company’s shares. Novaremed will control the timing and maximum amount of drawdown under this facility and has no minimum drawdown obligation. Concurrent with a public listing of Novaremed shares, the company will issue warrants to GEM to purchase shares of Novaremed.